Clinical Trial Update: Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stem cell transplantation with T-cell add-back for hematologic malignancies and bone marrow transplant rejection; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplant Rejection
• Hematologic Malignancies

Drugs mentioned

• Hematopoietic stem cell transplantation
• T-cell add-back therapy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hematologic Malignancies, Bone Marrow Transplant Rejection | Phase 2 | Status: COMPLETED | Results posted: 2012-05-28